在怀孕期间心脏骤停期间的挑战
Korneel Berteloot1, Marc Sabbe1
1Department of Emergency Medicine, University Hospital Gasthuisberg, Leuven, Belgium.
Resuscitation plus
|January 24, 2025
概括
一名怀孕的患者在延迟的临终剖腹产剖腹产后幸存下来,经历了69分钟的心脏骤停,突出了紧急产科护理的挑战和机械CPR设备的风险.
科学领域:
- 紧急医疗 紧急医疗
- 产科和妇科 产科和妇科
- 关键护理医学 关键护理医学
背景情况:
- 怀孕期间心肺衰竭带来了独特的管理挑战.
- 及时干预至关重要,死前剖腹产剖腹产指南建议在母亲崩后4分钟内进行.
- 机械心肺复苏装置和体外膜氧化 (ECMO) 是先进的生命支持选择.
研究的目的:
- 报告一个在怀孕患者中经历了长期心脏骤停后成功复苏和康复的病例.
- 为了说明在怀孕期间管理医院外心脏骤停的复杂性.
- 讨论延迟死前剖腹产和机械心肺复苏的使用所带来的影响.
主要方法:
- 一个病例报告详细介绍了36岁怀孕患者经历心肺衰竭的治疗方法.
- 包括先进的生命支持措施,包括机械CPR和考虑ECMO.
- 延迟的死前剖腹产剖腹产在医院转移后进行.
- 诊断性全身计算机断层扫描 (CT) 扫描自发循环 (ROSC) 恢复后.
主要成果:
- 患者经历了69分钟的心脏骤停,并出现了显著的代谢障碍.
- 进行了延迟的死前剖腹产剖腹产,但由于腹内出血和时间的流逝,ECMO没有启动.
- CT扫描显示了双边肺栓塞和4级肝损伤.
- 患者实现了ROSC和有利的神经恢复,在42天后出院.
结论:
- 这一案例强调了遵守死亡前剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产剖腹产
- 它强调了与机械心肺复苏器件相关的潜在并发症,例如腹内出血.
- 尽管逮捕时间长,受伤严重,但成功的结果是可能的,这强调了积极的复苏努力的价值.
更多相关视频
10:55A Piglet Perinatal Asphyxia Model to Study Cardiac Injury and Hemodynamics after Cardiac Arrest, Resuscitation, and the Return of Spontaneous Circulation
Published on: January 13, 2023
1.7K
07:02Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest
Published on: January 5, 2018
12.0K
相关概念视频
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
405
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
405
